Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
Due to the lack of both prospective trial and high-volume retrospective studies, the management of clinical N+ malignant pleural mesothelioma (MPM) patients remains highly debated. Node positive patients show poor survival compared with node-negative ones; thus, lymph node staging appears crucial in...
Guardado en:
Autores principales: | Sara Ricciardi, Francesco Carleo, Massimo O. Jaus, Marco Di Martino, Luigi Carbone, Alberto Ricci, Giuseppe Cardillo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b19da1ba6c4f479ca290b86230e90ba0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case–Control Study
por: Alberto Testori, et al.
Publicado: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi M, et al.
Publicado: (2017) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
por: Giuseppe Mangiameli, et al.
Publicado: (2021) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Cita Zupanc, et al.
Publicado: (2021) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Hiroto Yoneda, et al.
Publicado: (2021)